From the reviews of the second edition: “Neuro-oncology has benefitted significantly from modern translational research, in particular in the areas related to aggressiveness, invasion, and potential for recurrence. … Neurosurgeons, neurologists, oncologists, radiation oncologists, radiologists, and practitioners caring for patients with brain tumors are the main audience. … This is an excellent update. It is a valuable addition to any major academic library and a useful source of management information for neurologists, oncologists, neurosurgeons, radiation oncologists, and all professionals associated with the management of patients with these conditions.” (Celso Agner, Doody’s Review Service, May, 2010)